Phil Bardin is Professor of Respiratory Medicine in the Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Australia. Since 2008 he has been Director, Lung Sleep Allergy & Immunology, Monash University and Medical Centre, Melbourne.
He is recognised for investigation of obstructive lung diseases (particularly virus-asthma-COPD exacerbations) and has conducted extensive research of new asthma and COPD therapies. Recently research has also focussed on vocal cord dysfunction in obstructive lung diseases. He is a recipient of ongoing Australian NH&MRC funding, has chaired the Australian NH&MRC Grant Review Panel (Respiratory & Sleep Medicine) and served on the Australian NH&MRC Academy. His professional activities reflect a career-long commitment to research and medical education, particularly in the areas of asthma and COPD.
Currently he is co-Editor-in-Chief of Respirology, official journal of the TSANZ and APSR.
Professor Graham Hall Director, Synergy Health Solutions
Professor, Curtin University
Honorary Research Associate, Telethon Kids Institute
Professor Graham Hall is respiratory physiologist with an interest in the translation of research outcomes into clinical practice, in particular newer respiratory function tests in the identification of early onset lung disease to improve the diagnosis and management of respiratory disease in children. Graham was the Co-chair of the Global Lung Function Initiative for a number of years and heavily engaged in the implementation of new reference ranges into clinical practice.
Prof Hall is the Managing Director of Synergy Health Solutions, holds an Honorary Research Associate appointment at Telethon Kids and is an adjunct Professor at Curtin University.
Anne Holland is Professor of Physiotherapy and Head of Respiratory Research at Monash University and Alfred Health in Melbourne, Australia. She leads a research program that aims to improve the lives of people with chronic lung disease using non-pharmacological treatments. Her recent clinical trials have tested novel models of pulmonary rehabilitation to improve access and uptake, including low cost home-based models and telerehabilitation. Professor Holland has published over 380 peer reviewed journal articles and her publications have been cited over 25 000 times. She was co-chair and senior author for the recently published Clinical Practice Guidelines on Pulmonary Rehabilitation from the American Thoracic Society . Professor Holland is currently the President of the Thoracic Society of Australia and New Zealand.
Jay Horvat is a Professor of Immunology and Microbiology and Deputy Head of School of Biomedical Sciences and Pharmacy (Research) at the University of Newcastle and Hunter Medical Research Institute. He leads a team that specialises in the development of the most highly representative animal and cell models of many infection & inflammation-induced diseases. In combination with complementary clinical investigations, his team have used their unique models to make major advances in understanding mechanisms of pathogenesis of respiratory and reproductive tract diseases and identify novel therapies. One of his research interests includes understanding how the inter-relationship between immunity and iron metabolism affects the pathogenesis and susceptibility to infection in lung diseases such as asthma, COPD and IPF.
Professor Greg King is a staff specialist in the Department of Respiratory Medicine at Royal North Shore Hospital, Medical Director of the Respiratory Investigation Unit, and Research Leader of the Airway Physiology and Imaging Group at the Woolcock Institute of Medical Research. He is Conjoint Professor of Respiratory Medicine at the Northern Clinical School of the University of Sydney. He currently supervises PhD and other postgraduate students and uses complex lung function tests and imaging to study lung physiology and mechanics in airways diseases.
Edmund Lau is an academic respiratory physician working at Royal Prince Alfred Hospital, Sydney and Associate Professor of Medicine at the University of Sydney. He is the lead Respiratory Physician of the Pulmonary Hypertension Service at Royal Prince Alfred Hospital. He is the Medical Director of the Australian and New Zealand Pulmonary Hypertension Registry. He has authored more than 100 peer-reviewed publications, mostly on the topic of pulmonary hypertension. He is Associate Editor of Respirology and he participated in ERS Task Force on pulmonary circulation.
Professor YC Gary Lee is a clinician researcher and world leader in Pleural Medicine. He is a Professor of Respiratory Medicine at the University of Western Australia and leads the pleural service at Sir Charles Gairdner Hospital in Perth which is one of the busiest in Australasia. He established the Southern Hemisphere’s first translational pleural program in UWA and founded the Australasian Malignant PLeural Effusion network. His work has translated into clinical practice and informed clinical guidelines on many occasions and improved pleural care worldwide. He has published 300+ papers on pleural diseases (H-index 65), delivered 300+ invited lectures in 32 countries and won successive NHMRC Fellowships. He has trained many next generation pleural specialists from 10+ countries.
Research leadership: Prof Le Souëf is an academic scientist and respiratory and global health paediatrician. He has published >310 peer-reviewed publications, given >300 invited presentations at international scientific meetings, universities and institutes in 46 different countries, and had research collaborations in North and South America, Africa, Asia and Europe. He was Head, UWA School of Paediatrics for 20 years.
Respiratory research: He was worked in many areas of children’s respiratory research, particularly on early factors influencing children’s respiratory health. He currently heads the Mechanisms of Acute Viral Respiratory Infection in Children (MAVRIC) research team.
Future child health – the effect of environmental decline and increasing world population. He heads a new research group studying the effect of environmental deterioration and overpopulation on future children’s health.
Andreas L. Lopata is Professor of Medical Sciences in the College of public health, medical and veterinary sciences at James Cook University, Townsville, Australia. Since 2011 he is head of the Molecular Allergy Research Laboratory in the Australian Institute of Tropical Health and Medicine and since 2021 Prof Research Fellow in the Tropical Futures Institute at James Cook University-Singapore.
He is considered one of the world leaders on food allergies to seafood and has contributed to the development of national and international guidelines. His predominant focus has been on developing and employing advanced molecular technologies to investigate allergenic proteins, understand the interactions of allergens with the immune system and to develop novel interventions and therapeutics for food allergy.
Prof Lopata is principal investigator in the Centre for Food Allergy Research, a NHMRC Centre for Research Excellence since 2013, and the National Allergy Centre of Excellence, aiming at the facilitation and acceleration of allergy research to reduce the incidence of food allergies and translation into clinical practice.
He promotes translational science with over 250 publication and editorial board support on leading journals, including section editor Asia-Pacific of the WAO World Allergy Organisation Journal.
Alastair is Chair of Pharmacology and Therapeutics at University of Melbourne and Director of the ARC Industrial Transformation Centre for Personalised Therapeutic Technologies. He focusses on drug targeting in remodelling and inflammation. He is CSO and Director of TianLi Biotech and President of the Asia Pacific Federation of Pharmacologists.
Conjoint Associate Professor ARTHUR TENG is a senior staff specialist paediatrician, sleep physician and Head of the Department of Sleep Medicine at the Sydney Children’s Hospital, Randwick. Currently he is Conjoint Associate Professor of Medicine at the University of New South Wales (UNSW) and Clinical Senior Lecturer at the University of Tasmania. He was Respiratory Fellow and Chief Resident at the then Prince of Wales Children’s Hospital before training with Professor Colin Sullivan at the David Read Laboratories, University of Sydney, about ten years following the invention of CPAP. His clinical and research interests include the neuropsychological impact of sleep disorders in children, parasomnias, infantile obstructive sleep apnoea and childhood narcolepsy. He has published across the broad spectrum of paediatric sleep disorders in peer-reviewed journals including Sleep, J Applied Physiology, AJRCCM, ERJ, Sleep Medicine, J of Sleep Research, Respirology etc, and several text book chapters. He has supervised and is currently supervising Honours, Masters and PhD Projects through the Universities of Sydney and NSW. He has trained over 20 scientists, paediatric sleep, and respiratory physicians, from Australia and around the world including New Zealand, Hong Kong, China, Malaysia, Singapore, UK, India, Canada, Taiwan and Brazil.
Prof Bruce Thompson AM
B.App.Sci, CRFS, FANZSRS, FAPSR, FThorSoc, Phd
Head of Melbourne School of Health Sciences, University of Melbourne
Professor Bruce Thompson is an active clinical scientist, with over 30 years of experience working in hospitals, universities, the community sector and business. He is a key opinion leader in respiratory medicine nationally and internationally and sits on numerous national and international scientific and clinical committees, and boards for the profession, non-government and not for profit organisations, and industry.
He is a past president of the Thoracic Society of Australia and New Zealand. Prof Thompson developed an international reputation in pulmonary gas exchange physiology early in his career whilst doing his PhD in conjunction with the NASA physiology laboratory at the University of California San Diego. For the first 27 years of is career, he worked in clinical respiratory and sleep laboratories in major teaching hospitals. Throughout this time, he has developed and focused his research on the physiology of small airway function. The work is being approached on a number of fronts including physiology measurement, imaging, and mathematical modelling. Since that time Prof Thompson is now regarded as an international expert on clinical respiratory measurement. His published works include a book on lung function, as well as numerous book chapters and 165 peer-reviewed journal articles and official documents. As an established clinical researcher in lung function, asthma, allergies and respiratory health, Bruce has been awarded competitive grants of over $35.9M including NHMRC and ARC schemes. He is a past President of the Thoracic Society of Australia and New Zealand and was the first non-medical president in the history of the society, and is a Fellow of Australian and New Zealand Society of Respiratory Science, Thoracic Society of Australia and New Zealand and finally Asia Pacific Society of Respirology. He has extensive international reputation across medicine (respiratory and cardiovascular) and biomedical engineering. His international reputation has led to him being invited to participate on five American Thoracic Society/European Respiratory Society task forces and is currently a co-chair of the ATS/ERS task force writing the Lung Function interpretation document which is to be used across all lung function laboratories globally. Prof Thompson’s strengths is bringing non-traditional expertise to clinical healthcare and biomedicine, using his varied contacts and expertise to build truly cross-disciplinary projects.
Associate Professor Lauren Troy is a senior staff specialist in Respiratory Medicine at Royal Prince Alfred, Camperdown, Sydney, affiliated with the Central Clinical School, Sydney Medicine, University of Sydney, and Co-Director of the RPA Institute for Academic Medicine. She has clinical and research interests in interstitial lung disease, interventional pulmonology, and lung cancer. She was the principal investigator of the “COLDICE Study”, informing international guidelines on the role of transbronchial lung cryobiopsy in ILD diagnosis, and is an investigator on the Australian NHMRC Centre for Research Excellence in “Interstitial Lung Disease – towards individualised care” program.
Peter Wark is the Director of Cystic Fibrosis and RES2, AIRMED, Alfred Health, Melbourne. He is a conjoint Professor of Medicine at Monash University. He holds an honorary position as a senior staff specialist in Respiratory and Sleep Medicine at John Hunter Hospital, Newcastle and is an adjunct Professor with the University of Newcastle and senior affiliate researcher at the Hunter Medical Research Institute (HMRI) Immune Health Research programme at HMRI.
His research interests are; airway inflammation in the context of chronic airways disease, innate immunity, the role of infection in chronic airways disease and translational clinical trial design. His group has developed expertise in identifying respiratory viruses in airway secretions and developing an in-vitro cell culture model of the airway epithelium that we use to model the effect of infection and inflammation. His research focuses upon factors that increase susceptibility to virus infection in asthma, COPD, Cystic Fibrosis and bronchiectasis. Characterising airway inflammation and innate immune responses in chronic airways disease and applying this to clinical care, as well as the development of precise individualised management strategies.
He is currently on the board of directors for Cystic Fibrosis Australia and the National Asthma Council.
Professor Brendon Yee is a senior staff specialist in Respiratory and Sleep Medicine at Royal Prince Alfred Hospital, Camperdown, Sydney, affiliated with Central Clinical School, Sydney Medicine, University of Sydney. He is the Head, Discipline of Sleep Medicine, Sydney University. He is a Senior Researcher in the Sleep Research Group at the Woolcock Institute of Medical Research. He has a broad clinical and research intertest in both respiratory and non-respiratory sleep disorders and respiratory failure.
He is a current (and previous) investigator in a number of NHMRC grants, NHMRC Centre of Excellence and MRFF grants. He has published extensively (over 140 publications) in peer reviewed journals and textbooks.
He has trained and mentored many adult sleep medicine fellows/physicians from Australasia, Asia and Europe.
He was the previous Chair of the Professional Standards Committee at the Thoracic Society of Australia and New Zealand (TSANZ). He currently serves on the clinical committee in the Australasian Sleep Association (ASA). He is part of the International Sleep Research Training Program for the World Sleep Society.